Janux Therapeutics Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Janux therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Janux Therapeutics Daily Today - Breaking & Trending Today

Insider Selling: Janux Therapeutics, Inc. (NASDAQ:JANX) CFO Sells 822,721 Shares of Stock

Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) CFO Tighe Reardon sold 822,721 shares of the stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $54.75, for a total value of $45,043,974.75. Following the sale, the chief financial officer now directly owns 633,673 shares of […] ....

United States , Immunomodulators Tracir , Engagers Tractr , Tighe Reardon , William Blair , China Universal Asset Management Co , Janux Therapeutics Inc , Barclays Plc , Allspring Global Investments Holdings , Cerity Partners , Janux Therapeutics , Get Free Report , Global Investments Holdings , Universal Asset Management , Tumor Activatedt Cell Engagers , Tumor Activated Immunomodulators , Janux Therapeutics Daily ,

Janux Therapeutics, Inc. (NASDAQ:JANX) Major Shareholder Ventures Xi L.P. Avalon Sells 677,279 Shares

Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) major shareholder Ventures Xi L.P. Avalon sold 677,279 shares of Janux Therapeutics stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $54.75, for a total value of $37,081,025.25. Following the transaction, the insider now directly owns 3,271,216 shares of […] ....

United States , Immunomodulators Tracir , Engagers Tractr , Lester Murray Antman , William Blair , Nisa Investment Advisors , China Universal Asset Management Co , Janux Therapeutics Company Profile , Janux Therapeutics Inc , Proshare Advisors , Sg Americas Securities , Janux Therapeutics , Get Free Report , Investment Advisors , Universal Asset Management , Share Advisors , Murray Antman , Tumor Activatedt Cell Engagers , Tumor Activated Immunomodulators , Janux Therapeutics Daily ,

Janux Therapeutics, Inc. (NASDAQ:JANX) Major Shareholder Ventures Xi L.P. Avalon Sells 677,279 Shares

Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) major shareholder Ventures Xi L.P. Avalon sold 677,279 shares of Janux Therapeutics stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $54.75, for a total value of $37,081,025.25. Following the transaction, the insider now directly owns 3,271,216 shares of […] ....

United States , Immunomodulators Tracir , Lester Murray Antman , Engagers Tractr , William Blair , China Universal Asset Management Co , Nisa Investment Advisors , Janux Therapeutics Company Profile , Janux Therapeutics Inc , Sg Americas Securities , Proshare Advisors , Janux Therapeutics , Get Free Report , Investment Advisors , Universal Asset Management , Share Advisors , Murray Antman , Tumor Activatedt Cell Engagers , Tumor Activated Immunomodulators , Janux Therapeutics Daily ,

Jay Lichter Sells 1,500,000 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) Stock

Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) Director Jay Lichter sold 1,500,000 shares of the business’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $54.75, for a total transaction of $82,125,000.00. Following the sale, the director now directly owns 633,673 shares of the company’s stock, […] ....

United States , Immunomodulators Tracir , Engagers Tractr , Jay Lichter , William Blair , Artal Group , Janux Therapeutics Company Profile , Virtu Financial , Securities Exchange Commission , Janus Henderson Group , Janux Therapeutics Inc , Altitude Crest Partners Inc , Pricet Rowe Associates Inc , Janux Therapeutics , Get Free Report , Director Jay Lichter , Exchange Commission , Therapeutics Stock Down , Henderson Group , Altitude Crest Partners , Tumor Activatedt Cell Engagers , Tumor Activated Immunomodulators , Janux Therapeutics Daily ,

Research Analysts Set Expectations for Janux Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:JANX)

Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) – Stock analysts at HC Wainwright lowered their Q2 2024 EPS estimates for shares of Janux Therapeutics in a report issued on Monday, May 13th. HC Wainwright analyst S. Ramakanth now forecasts that the company will earn ($0.38) per share for the quarter, down from their previous estimate […] ....

United States , Engagers Tractr , Immunomodulators Tracir , William Blair , Janux Therapeutics Inc , China Universal Asset Management Co , Barclays Plc , Cantor Fitzgerald , Allspring Global Investments Holdings , Cerity Partners , Janux Therapeutics , Free Report , Janux Therapeutic , Get Free Report , Global Investments Holdings , Universal Asset Management , Tumor Activatedt Cell Engagers , Tumor Activated Immunomodulators , Janux Therapeutics Daily ,